Loading...
OTC Markets
Totals
Securities
12,306
Dollar Vol
$2.0B
Share Vol
4B
Trades
367,183

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

CSDX
CS Diagnostics Corp.

Common Stock

0.06

-0.009

-13.04%

0.047 / 0.06 (20000 x 89000)

Real-Time Best Bid & Ask: 05:00pm 07/11/2025
Delayed (15 Min) Trade Data: 12:00am 07/11/2025

CS Diagnostics Corp.

Stresemannallee 4b

Neuss 41460

Germany

Principal Executive Offices:

Stresemannallee 4b

Neuss 41460

Germany

Business Description
CS Diagnostics Corp. a renowned member of the CS Group, is a medical sector leader committed to advancing patient care through innovative solutions. With decades of experience in designing, manufacturing, and selling wellness and medical products, we have established ourselves as a reliable partner in global healthcare. Our team of experienced professionals works closely with top universities and experts to ensure we remain at the forefront of medical technology. Our flagship product, CS Protect Hydrogel is a pioneering advancement of medical innovation. This novel spacer gel is especially developed to distinguish between healthy and malignant cells during radiation therapy, greatly increasing ...
More
Financial Reporting
Reporting Status
Alternative Reporting Standard
Audited Financials
Audited
CIK
0001106861
Fiscal Year End
12/31
Company Officers & Contacts
Thomas Fahrhoefer
President

Mr. Fahrhoefer, born in 1970, is an expert in the field of pharmaceutical wholesaling and business development in the health care industry. After studying medicine and pharmacy since 2000 he obtained his diploma as a state-certified pharmaceutical sales representative. He was working for several years in the management of various German companies. In 2001 he joined Pfizer Germany and started his career in the pharmaceutical business. He was with Pfizer Germany from 2001 to 2003 before joining Sanochemia AG in 2004 in the global management of the Diagnostics business unit. In 2009 he founded CS Diagnostics in Germany which over the years has grown into the CS Diagnostics Group which includes CS Diagnostics Pharma GmbH, CS Interpharm LLC and CS Diagnostics Corp.

Thomas Josef Migotsch
Vice President, COO

Mr. Migotsch, born in 1977, received his university degree in business administration from the Otto-Friedrich University of Bamberg in 2002. After an internship at Sanofi Winthrop GmbH, he joined DaimlerChrysler in the Mercedes Benz Motorsport Division. Until 2006, he was responsible for press releases of the DTM, Formula 3 and Formula 1 (McLaren Mercedes) for DaimlerChrysler. From 2006 to the present day, he has taken a leading role in various projects in connection with professional motorsport and Formula 1 drivers. In 2012, he founded the Swiss consulting company SGM AG, with which he still develops strategy concepts and business plans for renowned companies.

Mohammad EsSayed
Vice President, CFO

With over 22 years of professional experience in finance and banking as well as in management positions, Mohammad EsSayed has all the qualifications that FZRO needs for the tasks ahead. Mohammad EsSayed has degrees in finance, including an MBA (Master of Business Administration) in International Corporate Banking, an MFP (Master Financial Professional) and CFA (Certified Financial Analyst) from the USA. FZRO will benefit from his many years of experience as CFO and Managing Director.

Elizabeth Pearce
Other

Llewellyn Angus
Other

John Hereward West
Other

Janel Luzana
Company Secretary

Board of Directors
Thomas Fahrhoefer
Chairman

Mr. Fahrhoefer, born in 1970, is an expert in the field of pharmaceutical wholesaling and business development in the health care industry. After studying medicine and pharmacy since 2000 he obtained his diploma as a state-certified pharmaceutical sales representative. He was working for several years in the management of various German companies. In 2001 he joined Pfizer Germany and started his career in the pharmaceutical business. He was with Pfizer Germany from 2001 to 2003 before joining Sanochemia AG in 2004 in the global management of the Diagnostics business unit. In 2009 he founded CS Diagnostics in Germany which over the years has grown into the CS Diagnostics Group which includes CS Diagnostics Pharma GmbH, CS Interpharm LLC and CS Diagnostics Corp.

Mahmoud A. Al-Sayyed
Independent Director

Mahmoud A. Al-Sayyed is a senior executive with 29+ years of intensive experience in senior management and advisory positions such in (1) Investment Advisory: IPO, Mergers and Acquisitions, Business Valuation, Feasibility Studies and Financial Modeling, (2) Corporate Strategy: Strategy Development and Execution, Corporate Performance and Portfolio Management, Business Planning and Budgeting and (3) Governance and Restructuring. In addition to various publications in recognized specialist journals, Mahmoud has many years of experience as a supervisory board member and board committee member.

Mohammad EsSayed
Audit Committee Member

With over 22 years of professional experience in finance and banking as well as in management positions, Mohammad EsSayed has all the qualifications that FZRO needs for the tasks ahead. Mohammad EsSayed has degrees in finance, including an MBA (Master of Business Administration) in International Corporate Banking, an MFP (Master Financial Professional) and CFA (Certified Financial Analyst) from the USA. FZRO will benefit from his many years of experience as CFO and Managing Director.

Thomas Josef Migotsch

Mr. Migotsch, born in 1977, received his university degree in business administration from the Otto-Friedrich University of Bamberg in 2002. After an internship at Sanofi Winthrop GmbH, he joined DaimlerChrysler in the Mercedes Benz Motorsport Division. Until 2006, he was responsible for press releases of the DTM, Formula 3 and Formula 1 (McLaren Mercedes) for DaimlerChrysler. From 2006 to the present day, he has taken a leading role in various projects in connection with professional motorsport and Formula 1 drivers. In 2012, he founded the Swiss consulting company SGM AG, with which he still develops strategy concepts and business plans for renowned companies.

Lauren Kate Ugur
Independent Director

Born in South Africa in 1984, British-German Dr. Lauren Ugur has had an impressive university career. In addition to her Bachelor of Arts with Honours, she completed her Postgraduate Diploma in Business Management (PDM) at the University of the Witwatersrand in Johannesburg, South Africa, before completing her MBA (Master of Business Administration) in Adelaide, Australia. Back in Darmstadt, Germany, she received her doctorate in philosophy. With this unique education, she has worked in various fields in business as well as teaching at universities and can draw on a wealth of international experience. With over a dozen publications, she is internationally recognized by expert readers.

Other Company Insiders

None

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
LAO Professionals

Suite 33, Hill Top Plaza, 13

Gwani Street, Zone 4, Wuse

Abuja 00234

Nigeria

Investor Relations/Marketing/Communications
ROSEWOOD REPUTATION LIMITED

80 Coleman Street

London, ENG W1U 7LP

United Kingdom

Securities Counsel
Mavacy, PLLC

801 W. Ann Arbor Trail,

Suite 230 Plymouth,

Plymouth, MI 48170

Profile Data
SIC - Industry Classification
2834 - Pharmaceutical preparations
Incorporation Information
WY, US, 2010
Employees
16 as of 08/09/2024
Shell
No
Products and Services

ISO 13485 and ISO 9001 certified international distribution and development of pharmaceuticals and medical devices.

Company Facilities

Headquarters: City of Neuss in Germany City of Bruckmuehl in Germany Dubai, United Arab Emirates

Company Notes
Formerly=FlashZero Corp. until 8-2023
Formerly=Children's Internet, Inc. (The) until 3-2015
Note=9-30-04 company is in the development stage
OTCQB Venture Market Logo
Joined OTCQB 11/2024
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.